Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply

N Engl J Med. 2021 Sep 16;385(12):1149. doi: 10.1056/NEJMc2108482. Epub 2021 Aug 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Critical Illness*
  • Humans
  • Receptors, Interleukin-6
  • SARS-CoV-2

Substances

  • Receptors, Interleukin-6